Controlled in vivo release of nicorandil from a carvone-based transdermal therapeutic system in human volunteers

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 13, Issue 1, 2006, Pages 69-77

  Krishnaiah, Y S R ^a   Al Saidan, S M ^a   Chandrasekhar, D V ^b   Satyanarayana, V ^c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b ANDHRA UNIVERSITY   (India)

^c Sipra Labs Pvt Ltd   (India)

Author keywords

Carvone; Human Volunteers; In Vivo Release; Nicorandil; Transdermal

Indexed keywords

CARVONE; NICORANDIL; VINYL ACETATE;

ABDOMEN; ADULT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SCREENING; DRUG STORAGE; DRUG SYNTHESIS; HEAT; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SKIN; STEADY STATE; TABLET; VOLUNTEER;

ADHESIVES; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DIFFUSION CHAMBERS, CULTURE; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; LACTOSE; MALE; MEMBRANES, ARTIFICIAL; METHYLCELLULOSE; MONOTERPENES; NICORANDIL; OXAZINES; RATS; SKIN ABSORPTION; SPECTROPHOTOMETRY, ULTRAVIOLET; VINYL COMPOUNDS;

EID: 30644462711     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500309107     Document Type: Article

References (21)

1. Al-Saidan, S. M., Krishnaiah, Y. S. R., Chandrasekhar, D. V., Lalla, J. K., Rama, B., Jayaram, B., and Bhaskar, P. 2004. Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil. Skin Pharmacol. Physiol. 17:310-320.
2. Diez, I., Colom, H., Moreno, J., Obach, R., Peraire, C., and Domenech, J. 1991. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci. 80:931-934.
3. El-Kattan, A. F., Asbill, C. S., Kim, N., and Michniak, B. B. 2001. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 215:229-240.
4. Frampton, J., Buckley, M. M., and Fitton, A. 1992. Nicorandil: a review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs 44:625-655.
5. Frydman, A. 1992. Pharmacokinetic profile of nicorandil in humans: an overview, J. Cardiovasc. Pharmacol. 20(Suppl 3):S34-S44.
6. Gao, S., and Singh, J. 1998. In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes. J. Control. Rel. 51:193-199.
7. Hunt, J. N. 1959. Gastric emptying and secretion in man. Physiol. Rev. 39:491-533.
8. Hunt, J. N., and Spurrell, W. R. 1951. The pattern of emptying of the human stomach. J. Physiol. 113:157-168.
9. Kerins, D. M., Robertson, R. M., and Robertson, D. 2001. Drugs used for the treatment of myocardial ischemia. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th ed., Hardman, J.G., and Limbird, L.E., 844. New York: McGraw Hill Medical Publishing Division.
10. Keshary, P. R., and Chien, Y. W. 1984. Mechanism of transdermal controlled nitroglycerin administration. Part 2. Assessment of rate controlling steps. Drug Dev. Ind. Pharm. 10:1663-1699.
11. Krishnaiah, Y. S. R., Satyanarayana, V., and Bhaskar, P. 2002. Influence of nerodilol on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int. J. Pharm. 247:91-102.
12. Krishnaiah, Y. S. R., Satyanarayana, V., and Bhaskar, P. 2003. Influence of menthol and pressure sensitive adhesives on the in vivo performance of membrane-moderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers. Eur. J. Pharm. Biopharm. 55:329-337.
13. Krishnaiah, Y. S. R. Al-Saidan, S. M., Chandrasekhar, D. V., and Lalla, J. K. 2004. Effect of nerodilol and carvone on the in vitro transdermal delivery of nicorandil. AAPSJ.6(4): abstract W4263.
14. Musolf, M. C. 1987. Pressure-sensitive adhesives: science and engineering. In Transdermal Controlled Systemic Medications, ed. Chien, Y.W., 93-112 New York: Marcel Dekker.
15. Prausnitz, M.R., Mitragotri, S., and Langer, R. 2004. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov 3:115-124.
16. Sato, K., Sugibayashi, K., Morimoto, Y., Omiya, H., and Enomoto, N. 1989. Prediction of the in-vitro human skin permeability of nicorandil from animal data. J. Pharm. Pharmacol. 41:379-383.
17. Sato, K., Sugibayashi, K., and Morimoto, Y. 1991. Species differences in percutaneous absorption of nicorandil. J. Pharm. Sci. 80:104-107.
18. Tipre, D. N., and Vavia, P. R. 2002. Formulation optimization and stability study of transdermal therapeutic system of nicorandil. Pharm. Dev. Technol. 7:325-332.
19. Williams, A. C., and Barry, B. W. 2004. Penetration enhancers. Adv. Drug Deliv. Rev. 56:603-618.
20. Zhao, K., and Singh, J. 1998. Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, D-nerodilol and menthone. J. Control. Rel. 55:253-260.
21. Zhao, K., and Singh, J. 1999. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J. Control. Rel. 62:359-366.